Insider Selling: Acadia Healthcare Company COO Sells 4,442 Shares of Stock (ACHC)
Acadia Healthcare Company (NASDAQ:ACHC) COO Ronald Morgan Fincher unloaded 4,442 shares of the stock on the open market in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $47.68, for a total value of $211,794.56. Following the sale, the chief operating officer now directly owns 121,480 shares in the company, valued at approximately $5,792,166. The sale was disclosed in a filing with the SEC, which is available at this link.
Shares of Acadia Healthcare Company (NASDAQ:ACHC) traded down 1.63% during mid-day trading on Wednesday, hitting $47.20. The stock had a trading volume of 585,031 shares. Acadia Healthcare Company has a 1-year low of $30.70 and a 1-year high of $53.87. The stock’s 50-day moving average is $42.72 and its 200-day moving average is $46.58. The company has a market cap of $2.397 billion and a P/E ratio of 46.45.
Acadia Healthcare Company (NASDAQ:ACHC) last announced its earnings results on Tuesday, April 29th. The company reported $0.28 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.28. The company had revenue of $206.10 million for the quarter, compared to the consensus estimate of $194.83 million. The company’s revenue for the quarter was up 24.4% on a year-over-year basis. Analysts expect that Acadia Healthcare Company will post $1.30 EPS for the current fiscal year.
A number of research firms have recently commented on ACHC. Analysts at Raymond James reiterated an “outperform” rating on shares of Acadia Healthcare Company in a research note on Wednesday. They now have a $55.00 price target on the stock, up previously from $49.00. Analysts at Ned Davis Research upgraded shares of Acadia Healthcare Company from a “sell” rating to a “neutral” rating in a research note on Monday, April 21st. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Acadia Healthcare Company currently has a consensus rating of “Buy” and an average target price of $52.36.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.